SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
14981106
Source:
http://linkedlifedata.com/resource/pubmed/id/14981106
Search
Subject
(
56
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0011108
,
umls-concept:C0023671
,
umls-concept:C0026882
,
umls-concept:C0029936
,
umls-concept:C0043210
,
umls-concept:C0282402
,
umls-concept:C0355642
,
umls-concept:C0376571
,
umls-concept:C0445202
,
umls-concept:C0677582
pubmed:issue
6
pubmed:dateCreated
2004-3-15
pubmed:abstractText
The decision about prophylactic oophorectomy is difficult for many premenopausal women with BRCA1/2 mutations because of concerns and controversy about the use of hormone replacement therapy (HRT) after oophorectomy.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/14981106-14981100
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0732-183X
pubmed:author
pubmed-author:ArmstrongKatrinaK
,
pubmed-author:RandallThomasT
,
pubmed-author:RubinStephen CSC
,
pubmed-author:SchwartzJ SanfordJS
,
pubmed-author:WeberBarbaraB
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1045-54
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:14981106-Adult
,
pubmed-meshheading:14981106-Age Factors
,
pubmed-meshheading:14981106-Cohort Studies
,
pubmed-meshheading:14981106-Decision Support Techniques
,
pubmed-meshheading:14981106-Estrogen Replacement Therapy
,
pubmed-meshheading:14981106-Female
,
pubmed-meshheading:14981106-Genes, BRCA1
,
pubmed-meshheading:14981106-Genes, BRCA2
,
pubmed-meshheading:14981106-Genetic Predisposition to Disease
,
pubmed-meshheading:14981106-Humans
,
pubmed-meshheading:14981106-Life Expectancy
,
pubmed-meshheading:14981106-Markov Chains
,
pubmed-meshheading:14981106-Middle Aged
,
pubmed-meshheading:14981106-Mutation
,
pubmed-meshheading:14981106-Ovarian Neoplasms
,
pubmed-meshheading:14981106-Ovariectomy
,
pubmed-meshheading:14981106-Postoperative Care
,
pubmed-meshheading:14981106-Risk
,
pubmed-meshheading:14981106-Treatment Outcome
pubmed:year
2004
pubmed:articleTitle
Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: a decision analysis.
pubmed:affiliation
Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6021, USA. karmstro@mail.med.upenn.edu
pubmed:publicationType
Journal Article